Erratum: Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo (Cell Reports (2012) 2(2) (270–285) (S2211124712001994) (10.1016/j.celrep.2012.07.003));Luminal Iron Levels Govern Intestinal Tumorigenesis after Apc Loss In Vivo

Cell Reports

Volumn 2, Issue 2, 2012, Pages 270-282

  Radulescu, Sorina ^a   Brookes, Matthew J ^b   Salgueiro, Pedro ^a   Ridgway, Rachel A ^a   McGhee, Ewan ^a   Anderson, Kurt ^a   Ford, Samuel J ^b   Stones, Daniel H ^b   Iqbal, Tariq H ^b   Tselepis, Chris ^b   Sansom, Owen J ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; DMT1 PROTEIN; IRON; TFR1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APC GENE; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; GENE; GENE DELETION; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IN VIVO STUDY; INTESTINE TUMOR; IRON METABOLISM; IRON THERAPY; MALE; MOUSE; NONHUMAN; WNT SIGNALING PATHWAY;

MURINAE;

EID: 84865741302     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.10.028     Document Type: Erratum

References (43)

1. Barker N., van Es J.H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P.J., Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007, 449:1003-1007.
2. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000, 103:311-320.
3. Biteau B., Hochmuth C.E., Jasper H. JNK activity in somatic stem cells causes loss of tissue homeostasis in the aging Drosophila gut. Cell Stem Cell 2008, 3:442-455.
4. Brookes M.J., Hughes S., Turner F.E., Reynolds G., Sharma N., Ismail T., Berx G., McKie A.T., Hotchin N., Anderson G.J., et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 2006, 55:1449-1460.
5. Brookes M.J., Boult J., Roberts K., Cooper B.T., Hotchin N.A., Matthews G., Iqbal T., Tselepis C. A role for iron in Wnt signalling. Oncogene 2008, 27:966-975.
6. Chua A.C., Klopcic B., Lawrance I.C., Olynyk J.K., Trinder D. Iron: an emerging factor in colorectal carcinogenesis. World J. Gastroenterol. 2010, 16:663-672.
7. de Alboran I.M., O'Hagan R.C., Gärtner F., Malynn B., Davidson L., Rickert R., Rajewsky K., DePinho R.A., Alt F.W. Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity 2001, 14:45-55.
8. de Lau W., Barker N., Low T.Y., Koo B.K., Li V.S., Teunissen H., Kujala P., Haegebarth A., Peters P.J., van de Wetering M., et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011, 476:293-297.
9. Edgren G., Reilly M., Hjalgrim H., Tran T.N., Rostgaard K., Adami J., Titlestad K., Shanwell A., Melbye M., Nyrén O. Donation frequency, iron loss, and risk of cancer among blood donors. J. Natl. Cancer Inst. 2008, 100:572-579.
10. Ireland H., Kemp R., Houghton C., Howard L., Clarke A.R., Sansom O.J., Winton D.J. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract: effect of loss of beta-catenin. Gastroenterology 2004, 126:1236-1246.
11. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., Zeleniuch-Jacquotte A., Akhmedkhanov A., Riboli E. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int. J. Cancer 1999, 80:693-698.
12. Le N.T., Richardson D.R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochim. Biophys. Acta 2002, 1603:31-46.
13. Lee D.H., Anderson K.E., Harnack L.J., Folsom A.R., Jacobs D.R. Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J. Natl. Cancer Inst. 2004, 96:403-407.
14. Lewis A., Segditsas S., Deheragoda M., Pollard P., Jeffery R., Nye E., Lockstone H., Davis H., Clark S., Stamp G., et al. Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5. Gut 2010, 59:1680-1686.
15. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 1995, 23:1686-1690.
16. Lund E.K., Wharf S.G., Fairweather-Tait S.J., Johnson I.T. Increases in the concentrations of available iron in response to dietary iron supplementation are associated with changes in crypt cell proliferation in rat large intestine. J. Nutr. 1998, 128:175-179.
17. Mainous A.G., Gill J.M., Everett C.J. Transferrin saturation, dietary iron intake, and risk of cancer. Ann. Fam. Med. 2005, 3:131-137.
18. Merlos-Suárez A., Barriga F.M., Jung P., Iglesias M., Céspedes M.V., Rossell D., Sevillano M., Hernando-Momblona X., da Silva-Diz V., Muñoz P., et al. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell 2011, 8:511-524.
19. Nelson R.L. Iron and colorectal cancer risk: human studies. Nutr. Rev. 2001, 59:140-148.
20. Nelson R.L., Davis F.G., Persky V., Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 1995, 76:875-879.
21. O'Donnell K.A., Yu D., Zeller K.I., Kim J.W., Racke F., Thomas-Tikhonenko A., Dang C.V. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol. Cell. Biol. 2006, 26:2373-2386.
22. Pigeon C., Turlin B., Iancu T.C., Leroyer P., Le Lan J., Deugnier Y., Brissot P., Loréal O. Carbonyl-iron supplementation induces hepatocyte nuclear changes in BALB/CJ male mice. J. Hepatol. 1999, 30:926-934.
23. Pollard P., Deheragoda M., Segditsas S., Lewis A., Rowan A., Howarth K., Willis L., Nye E., McCart A., Mandir N., et al. The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression. Gastroenterology 2009, 136:2204-2213.
24. Potter S.S., Brunskill E.W. Laser capture. Methods Mol. Biol. 2012, 886:211-221.
25. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Nathke I.S., et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004, 18:1385-1390.
26. Sansom O.J., Meniel V.S., Muncan V., Phesse T.J., Wilkins J.A., Reed K.R., Vass J.K., Athineos D., Clevers H., Clarke A.R. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007, 446:676-679.
27. Shaheen N.J., Silverman L.M., Keku T., Lawrence L.B., Rohlfs E.M., Martin C.F., Galanko J., Sandler R.S. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J. Natl. Cancer Inst. 2003, 95:154-159.
28. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997, 278:120-123.
29. Song S., Christova T., Perusini S., Alizadeh S., Bao R.Y., Miller B.W., Hurren R., Jitkova Y., Gronda M., Isaac M., et al. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. Cancer Res. 2011, 71:7628-7639.
30. Soyars K.E., Fischer J.G. Iron supplementation does not affect cell proliferation or aberrant crypt foci development in the colon of Sprague-Dawley rats. J. Nutr. 1998, 128:764-770.
31. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992, 256:668-670.
32. Theurl I., Ludwiczek S., Eller P., Seifert M., Artner E., Brunner P., Weiss G. Pathways for the regulation of body iron homeostasis in response to experimental iron overload. J. Hepatol. 2005, 43:711-719.
33. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 1996, 20:553-566.
34. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci. 2009, 100:9-16.
35. van der Flier L.G., Sabates-Bellver J., Oving I., Haegebarth A., De Palo M., Anti M., van Gijn M.E., Suijkerbuijk S., van de Wetering M., Marra G., Clevers H. The intestinal Wnt/TCF signature. Gastroenterology 2007, 132:628-632.
36. van der Flier L.G., van Gijn M.E., Hatzis P., Kujala P., Haegebarth A., Stange D.E., Begthel H., van den Born M., Guryev V., Oving I., et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 2009, 136:903-912.
37. Ward D.G., Roberts K., Brookes M.J., Joy H., Martin A., Ismail T., Spychal R., Iqbal T., Tselepis C. Increased hepcidin expression in colorectal carcinogenesis. World J. Gastroenterol. 2008, 14:1339-1345.
38. Weinberg E.D. Association of iron with colorectal cancer. Biometals 1994, 7:211-216.
39. Weinberg E.D. The role of iron in cancer. Eur. J. Cancer Prev. 1996, 5:19-36.
40. Whitnall M., Howard J., Ponka P., Richardson D.R. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci. USA 2006, 103:14901-14906.
41. Continuous Update Project Interim Report Summary 2011, World Cancer Research Fund / American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer.
42. Wu K.J., Polack A., Dalla-Favera R. Coordinated regulation of iron-controlling genes, H-ferritin and IRP2, by c-MYC. Science 1999, 283:676-679.
43. Zacharski L.R., Chow B.K., Howes P.S., Shamayeva G., Baron J.A., Dalman R.L., Malenka D.J., Ozaki C.K., Lavori P.W. Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial. J. Natl. Cancer Inst. 2008, 100:996-1002.